These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 16252569)
21. Renal protective effects and prevention of contrast-induced nephropathy by atrial natriuretic peptide can it work? Haase M; Haase-Fielitz A; Habedank D; Anker SD J Am Coll Cardiol; 2009 Sep; 54(13):1192-3; author reply 1193-4. PubMed ID: 19761946 [No Abstract] [Full Text] [Related]
22. Determinants of amount of contrast utilized in patients undergoing percutaneous coronary procedures. Pradhan J; Niraj A; Afonso L Coron Artery Dis; 2007 Jun; 18(4):275-82. PubMed ID: 17496491 [TBL] [Abstract][Full Text] [Related]
23. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303 [TBL] [Abstract][Full Text] [Related]
24. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825 [TBL] [Abstract][Full Text] [Related]
25. Contrast-induced nephropathy and cardiac surgery. Bedi HS; Singh RP; Sengar B; Sachdeva G Indian Heart J; 2004; 56(3):262-3. PubMed ID: 15584579 [No Abstract] [Full Text] [Related]
26. [Cholesterol embolism after percutaneous transluminal coronary angioplasty procedure: a case report]. Sakamoto T; Inoue N; Kunitomo K; Tokura T; Matsuo A; Inoue K; Fujita H; Miyao K; Ohta B; Kitamura M; Kato G J Cardiol; 2001 Feb; 37(2):99-102. PubMed ID: 11255701 [TBL] [Abstract][Full Text] [Related]
27. Prevention of contrast media nephrotoxicity--the story so far. Morcos SK Clin Radiol; 2004 May; 59(5):381-9. PubMed ID: 15081843 [TBL] [Abstract][Full Text] [Related]
28. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality. Roghi A; Savonitto S; Cavallini C; Arraiz G; Angoli L; Castriota F; Bernardi G; Sansa M; De Servi S; Pitscheider W; Danzi GB; Reimers B; Klugmann S; Zaninotto M; Ardissino D; J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):375-81. PubMed ID: 18334892 [TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous atrial natriuretic peptide on pulmonary dysfunction and renal function following burn shock. Oda J; Kasai K; Noborio M; Aoki Y; Yamashita K; Inoue T; Ueyama M; Yukioka T J Trauma; 2009 May; 66(5):1281-5. PubMed ID: 19430227 [TBL] [Abstract][Full Text] [Related]
30. [Complications after administration of contrast media in high-risk patients. Is a prophylactic dialysis meaningful?]. Liebl R; Krämer BK Dtsch Med Wochenschr; 1996 Nov; 121(47):1475-9. PubMed ID: 8983899 [No Abstract] [Full Text] [Related]
31. Contrast-induced nephropathy: a review. Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365 [TBL] [Abstract][Full Text] [Related]
33. [Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease]. Shavit L; Lifschitz M; Lachish T; Rosenmann D; Balkin J; Slotki I Harefuah; 2007 Sep; 146(9):655-9, 736. PubMed ID: 17969299 [TBL] [Abstract][Full Text] [Related]
34. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention. Bachorzewska-Gajewska H; Malyszko J; Malyszko JS; Musial W; Dobrzycki S Nephrology (Carlton); 2006 Dec; 11(6):549-54. PubMed ID: 17199796 [TBL] [Abstract][Full Text] [Related]
35. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer? Vesely DL Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258 [TBL] [Abstract][Full Text] [Related]
36. [Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines]. Meschi M; Detrenis S; Savazzi G Recenti Prog Med; 2008 Mar; 99(3):155-62. PubMed ID: 18488528 [TBL] [Abstract][Full Text] [Related]
37. Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention. Rubboli A; Colletta M; Herzfeld J; Sangiorgio P; Di Pasquale G Coron Artery Dis; 2007 May; 18(3):193-9. PubMed ID: 17429293 [TBL] [Abstract][Full Text] [Related]
38. Reaction to intravenous contrast media mimicking intracerebral hemorrhage after percutaneous coronary intervention. Korn-Lubetzki I; Rosenmann D; Steiner-Birmanns B Med Sci Monit; 2008 Dec; 14(12):CS142-4. PubMed ID: 19043373 [TBL] [Abstract][Full Text] [Related]